B · Normal
[Lifang Pharmaceuticals: Celecoxib Tramadol Hydrochloride Tablets Clinical Trial Application Accepted] On September 18, Cubic Pharmaceuticals (003020.SZ) announced that the company received the "Acceptance Notice" for the drug registration clinical trial application of Celecoxib Tramadol Hydrochloride Tablets issued by the State Food and Drug Administration. The proposed indication is the treatment of short-term moderate to severe acute somatic pain in adults. The original research drug of this product will be approved for marketing in the United States in 2021, but has not yet been launched in China. The company is the first domestic enterprise to apply for clinical trials.
A-share announcement express 🕐 2026-09-18 15:51
#clinical trial #A-share announcement express
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Yahong Pharmaceutical: APL-2501 has completed the enrollment of the first subje 09-22 17:43 [Tianchuang Fashion: Plans to change securities abbreviation to "Tianchuang Shar 09-22 17:34 [Honghe Technology: Shareholders reduced their holdings by 2.5% in total] On Sep 09-22 17:27 [Happy Home: The controlling shareholder plans to transfer 3.80% of the shares t 09-22 17:24 [Mingxin Xuteng: Shareholders holding more than 5% of the shares plan to transfe 09-22 17:21 [Yinglite: Temporary suspension of production of some production devices] On Sep 09-22 17:08

Comments

0/500
Captcha (click to refresh)
No comments yet